share_log

HC Wainwright & Co. Maintains Buy on Travere Therapeutics, Maintains $17 Price Target

HC Wainwright & Co. Maintains Buy on Travere Therapeutics, Maintains $17 Price Target

HC Wainwright & Co.维持对Travere Therapeutics的买入,维持17美元的目标股价
Moomoo 24/7 ·  03/13 09:45

HC Wainwright & Co. analyst Ed Arce maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and maintains $17 price target.

HC Wainwright & Co. 分析师埃德·阿尔塞维持Travere Therapeutics(纳斯达克股票代码:TVTX)的买入并维持17美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发